Berlin pharmaceutical companies pursued probiotics-based therapeutic approaches Berlin, December 1st, 2010 the newly founded ORGANOBALANCE medical AG takes today its operating business. Managing partner of ORGANOBALANCE GmbH, and Dr. Bernd Wegener, Chairman of the Board of the Federal Association of the pharmaceutical industry (BPI) E.v. and founder and former Chairman of the Board of the B was founded the company of Prof. Dr. Christine lang, R A H M S Group.
Facts about ORGANOBALANCE medical AG 1 funded business purpose the ORGANOBALANCE medical AG and promotes the research and development of novel therapeutic approaches of ORGANOBALANCE GmbH, based on positive-acting micro-organisms, so-called specific probiotic cultures. It aims to create patent protected ingredients for new drugs and medical devices. A partnering of the achieved research and development results is not thereby excluded. In this way, new treatment options for so far not satisfactory can be handled should Indications emerge. 2 the Board of Directors of the joint-stock company Board of Directors consists of the two company founders.
Her research interests lie in the scientific technical area (Mrs. Prof. C. long, Chief Scientific Officer) and in terms of business and legal (Dr. B. Wegener, Chief Executive Officer). Due to its past and current activities, both Board members have extensive experience and recognized expertise in their areas of work. 3. supervisory board the Supervisory Board of the new company form: lawyer Donald Laher, Berlin (Chairman) Dipl.-ing. Joachim lang, Ulm (acting) Chairman) Professor Dr Ulf Stahl, Berlin 4. motivation of entrepreneurship for Mrs Prof. and Mr Dr. Wegener have the ORGANOBALANCE medical AG founded with the aim, to transfer the patented results of own longtime research of ORGANOBALANCE GmbH into marketable products and to the fact this potential. The ORGANOBALANCE GmbH continues their successful research and development work in the best way track as a service provider.